Dr. Hammers Discusses Combining IDO and PD-1 Inhibitors in RCC
December 1st 2017
Hans J. Hammers, MD, PhD, associate professor, Internal Medicine, UT Southwestern Medical Center, discusses the potential combination of IDO inhibitors and PD-1 inhibitors in renal cell carcinoma.